Navigation Links
ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
Date:12/3/2008

stem and AXP offerings.

-- The market program for the Company's Res-Q(TM), a point-of-care solution for bone marrow processing and peripheral blood platelet concentration, is on track for launch in the equine market in the Company's fiscal 2009 third quarter, with sales in the human market expected to begin in the fourth quarter of 2009.

-- The Company remains on track to complete the disposition of its ThermoLine(TM) business during the current quarter.

Conference Call

The Company will hold a conference call to discuss this announcement at 5:30 a.m., Pacific Standard Time (8:30 a.m., Eastern Standard Time), Thursday, December 4. The call can be accessed by calling (800) 860-2422 (domestic) or (412) 858-4600 (international), passcode ThermoGenesis. The webcast will also be available on the Company's website at http://www.thermogenesis.com/investors-webcasts-and-calls.aspx. A replay of the call will be available by calling (877) 344-7529 (domestic), or (412) 317-0088 (international), passcode 385107#, or via the Company's website.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leader in developing and manufacturing automated blood processing systems and disposable products that enable the manufacture, preservation and delivery of cell and tissue therapy products. These products include:

-- The BioArchive(R) System, an automated cryogenic device, is used by cord blood stem cell banks in more than 25 countries for cryopreserving and archiving cord blood stem cell units for transplant.

-- AXP(TM) AutoXpress Platform (AXP(TM)) is a proprietary family of automated devices that includes the AXP and the MarrowXpress(TM) and companion sterile blood processing di
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. ThermoGenesis Reports First Quarter 2009 Results
2. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
3. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
4. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
5. ThermoGenesis Corp. Reports First Quarter 2008 Results
6. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
7. Integrated Benefits Institute Announces Availability of 2007 IBI Benchmarking Data for Employers to Evaluate Effectiveness of their Health and Productivity Programs
8. Vertellus Specialties Announces Price Change
9. HLTH Corporation Announces Final Results of Its Tender Offer
10. Hill-Rom Announces First Quarter 2009 Dividend
11. Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... , SCOTTSDALE, Ariz., Dec. 4 He...naged, non-traded, real estate investment trust, a...ement to acquire a three building medical office p...Texas, and Fort Wayne, Indiana for approximately $...ject to the satisfaction of a number of conditions...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/...orm would control health care costs, Leapfrog,s pu...rough example -- delivering the best quality care ...f efficiency. Thirty-four urban, eight children,s ...pfrog Top Hospitals, based on results from The Lea...
(Date:12/4/2009)...rking with mice, scientists at Johns Hopkins publi...own that a protein made by a gene called "Twist" m...distinguish stem cells that drive aggressive, meta...s. , Building on recent work suggesting that it ...ast tumors that drives breast cancer, scientists h...
(Date:12/4/2009)... Dental tourism is a phenomenon...an alternative to the high price of dental work in...rch for lower priced dental care, people have foun...s a dental tourist destination. , ...n business for more than 6 years, Mexican Dental V...
(Date:12/4/2009)..., BOSTON, Dec. 4 Substantial pr... healthcare community,s ability to diagnose and tr...ress in epilepsy management has not reached most o...g many of the nearly three million people in the U...g to Steven C. Schachter, M.D., president of the A...
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4
...s, don,t take candy from strangers, expert says , ... Halloween right around the corner, many parents a...e. , According to Meridith Sonnett, director of p...nd safe occasion for everyone. , She particularly ...
...it , , FRIDAY, Oct. 31 (HealthDay News) --...earch shows that 40 percent of women report sexual...t it. , "The good news is that 12 percent is a ver...arvard Medical School and director of the Vincent ...
...e Guidance, HOUSTON, Oct. 31 Cyberonics, Inc. (N...Medicare and Medicaid Services,(CMS) has published...m,(OPPS) Final Rule and Ambulatory Payment Classif... generators and $7,234,for insertion of associated...
...ls attending four-day event, SAN DIEGO, Oct. 31 ...tal health issues, the 2008 U.S. Psychiatric and M... sessions today to major,depressive disorder and i...professionals attended,yesterday,s opening session...
... New Application of Tissue of,Origin Test, SUNNYV...cular diagnostics company focused on oncology, wil...ion based Pathwork(R) Tissue of Origin,Test at the...ary Tumor Site in Patients with Carcinoma of Unkno...
... LLC, a global,leader in manufacturing and product...dvanced and highly regulated industries, announced...n providing services and,products to the aerospace... CEO John Todd notes, "Customers all over the,worl...
Other Medicine News:Health News:Family Halloween Safety Can Be Fiendishly Simple 2Health News:Almost Half of Women Have Sexual Problems 2Health News:Almost Half of Women Have Sexual Problems 3Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 2Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 3Health News:Psychiatric Congress Focus on Depressive Disorders Continues Through the Weekend 2Health News:Pathwork Tissue of Origin Test Shows Potential to Aid in the Diagnosis of Cancer of Unknown Primary 2Health News:Pathwork Tissue of Origin Test Shows Potential to Aid in the Diagnosis of Cancer of Unknown Primary 3Health News:Intercim Announces Australia-Based Memko to Resell its Pertinence Suite Powered by Velocity in Asia Pacific 2
(Date:12/3/2009)..., , MADISON, N.J., Dec. 3 /PRNewswire-Fir... patient,s risk of developing a potentially life-t...armaceutical therapies or chemicals is one of seve...ostics leader Quest Diagnostics (NYSE: DGX ) wil...tology (ASH) Annual Meeting and Exposition, Decemb...
(Date:12/3/2009)..., , SAN DIEGO, Dec. 3 /PRNewswire-FirstCa...nounced today that it has entered into a new lease...GN ) for approximately 131,000 square feet of addi...ace at The Landmark at Eastview campus in Tarrytow...3. This lease of additional space was completed ap...
(Date:12/3/2009)..., , HOERSHOLM, Denmark and SA..., - SPC3649 Successfully Inhibits miR-122, ...tion, Thereby Significantly Reducing Hepatitis C,V... Infected With the,Hepatitis C Virus , - ...Viral Resistance and,No Serious Adverse Events in ...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Understanding a cells split personality aids synthetic circuits 10253 1Understanding a cells split personality aids synthetic circuits 10253 2Understanding a cells split personality aids synthetic circuits 10253 3Team finds a better way to watch bacteria swim 10251 1Team finds a better way to watch bacteria swim 10251 21 Million Preemie Babies Die Each Year 3A Report 58826 11 Million Preemie Babies Die Each Year 3A Report 58826 21 Million Preemie Babies Die Each Year 3A Report 58826 3
... April 9, 2008 New devices and research for,mecha...ational Institutes,of Health (NIH) National Heart,...latory Support Program will be discussed at the In...tion (ISHLT) 28th Annual Meeting and,Scientific Se...ston,Marriott Copley Place and Hynes Convention Ce...
...K, April 9, 2008 Intra-Cellular Therapies, Inc.,t...s ongoing development,programs for ITI-007, the Co...ist/dopamine receptor phosphoprotein modulator (DP..., which are in development for,schizophrenia and s...strate,ITI-007 has preclinical activity both in vi...
Other Medicine Technology:New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007 3
Osher Lid Speculum
Cook Eye Speculum - Infant
Kawesch-Lancaster Eye Speculum
Knapp Eye Speculum
Medicine Products: